Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21768810 | 0.79 | ALDH1A1 (0.62) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL991531 | 0.76 | ALDH1A1 (0.62) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL522510 | 0.76 | ALDH1A1 (0.62) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL6946124 | 0.76 | ALDH1A1 (0.62) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL24250956 | 0.75 | ALDH1A1 (0.56) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL3756497 | 0.74 | ALDH1A1 (0.60) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| Ammonia Solution, Strong SCHEMBL27451848 | 0.74 | ALDH1A1 (0.60) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL24347012 | 0.74 | ALDH1A1 (0.60) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL1706652 | 0.74 | ALDH1A1 (0.60) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL28246707 | 0.74 | ALDH1A1 (0.60) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180044337-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. (US) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044337-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | HCCS, CYCS, CBR3 | ALDH1A1 1399/4885TDP1 3200/4885MAPK1 4238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.